Scientific Session

When Cancer Therapy Triggers Autoimmunity: The Rheumatologist’s Role in Immune Checkpoint Inhibitors Toxicity

Speaker(s)

• ES

  Elad Sharon, MD,MPH

  Dana-Farber Cancer Institute
  Newton, MA, United States

  Disclosure(s): D. E. Shaw Research: Consultant (Terminated, January 11, 2024); Mallincrkrodt Pharmaceuticals: Advisor or Review Panel Member (Terminated, November 28, 2024)